DE69424051D1 - Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität - Google Patents

Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität

Info

Publication number
DE69424051D1
DE69424051D1 DE69424051T DE69424051T DE69424051D1 DE 69424051 D1 DE69424051 D1 DE 69424051D1 DE 69424051 T DE69424051 T DE 69424051T DE 69424051 T DE69424051 T DE 69424051T DE 69424051 D1 DE69424051 D1 DE 69424051D1
Authority
DE
Germany
Prior art keywords
antimicrobe
cancer
rapamycin derivative
immunomodulative
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69424051T
Other languages
English (en)
Other versions
DE69424051T2 (de
Inventor
Douglas Ford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69424051D1 publication Critical patent/DE69424051D1/de
Publication of DE69424051T2 publication Critical patent/DE69424051T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69424051T 1993-07-31 1994-07-25 Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität Expired - Fee Related DE69424051T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939315914A GB9315914D0 (en) 1993-07-31 1993-07-31 Novel compound
PCT/GB1994/001600 WO1995004060A1 (en) 1993-07-31 1994-07-25 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity

Publications (2)

Publication Number Publication Date
DE69424051D1 true DE69424051D1 (de) 2000-05-25
DE69424051T2 DE69424051T2 (de) 2000-09-14

Family

ID=10739787

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424051T Expired - Fee Related DE69424051T2 (de) 1993-07-31 1994-07-25 Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität

Country Status (6)

Country Link
US (1) US5712129A (de)
EP (1) EP0711297B1 (de)
JP (1) JPH09501563A (de)
DE (1) DE69424051T2 (de)
GB (1) GB9315914D0 (de)
WO (1) WO1995004060A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE37421E1 (en) 1993-07-16 2001-10-23 Smithkline Beecham Corporation Rapamycin derivatives
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
EP0937082A2 (de) 1996-07-12 1999-08-25 Ariad Pharmaceuticals, Inc. Nicht immunhemmende antifungale rapaloge
US6486892B1 (en) * 1999-04-07 2002-11-26 Joseph L. Stern System and method for accessing, manipulating and viewing internet and non-internet related information and for controlling networked devices
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
CA2383451A1 (en) 1999-08-24 2001-03-01 Ariad Gene Therapeutics, Inc. 28-epirapalogs
EP2277898A3 (de) 2002-07-16 2011-06-01 Biotica Technology Limited Rapamycinähnliche Substanzen
AU2003293529A1 (en) 2002-12-16 2004-07-29 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
GB0504994D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Novel compounds
GB0504995D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Use of a compound
US20100061994A1 (en) * 2005-03-11 2010-03-11 Rose Mary Sheridan Medical uses of 39-desmethoxyrapamycin and analogues thereof
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
US9083932B2 (en) 2009-03-25 2015-07-14 Eloy Technology, Llc Method and system for providing information from a program guide
US9445158B2 (en) 2009-11-06 2016-09-13 Eloy Technology, Llc Distributed aggregated content guide for collaborative playback session
BR112014011645A2 (pt) 2011-11-15 2017-05-02 Novartis Ag combinação de um inibidor da fosfoinositida 3-quinase e um modulador da quinase janus 2-transdutor de sinal e ativador da via de transcrição 5
WO2014006115A1 (en) 2012-07-06 2014-01-09 Novartis Ag Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the il-8/cxcr interaction
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US5776943A (en) * 1991-05-14 1998-07-07 American Home Products Corporation Rapamycin metabolites
US5256790A (en) * 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
ES2258763T3 (es) * 1992-10-13 2006-09-01 Wyeth Carbamatos de rapamicina.
US5310903A (en) * 1993-03-05 1994-05-10 Merck & Co., Inc. Imidazolidyl rapamycin derivatives
US5310901A (en) * 1993-03-05 1994-05-10 Merck & Co., Inc. O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynlheteroarylrapamycin derivatives

Also Published As

Publication number Publication date
JPH09501563A (ja) 1997-02-18
GB9315914D0 (en) 1993-09-15
EP0711297A1 (de) 1996-05-15
DE69424051T2 (de) 2000-09-14
WO1995004060A1 (en) 1995-02-09
EP0711297B1 (de) 2000-04-19
US5712129A (en) 1998-01-27

Similar Documents

Publication Publication Date Title
DE69424051D1 (de) Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität
CY2005010I1 (el) Ο - αλκυλιωμενα παραγωγα ραπαμυκινης και η χρηση τους, ιδιαιτερως ως ανοσοκατασταλτικων
LV11547A (lv) Makrolidi ar imunodepresantu aktivitati
DE69425782D1 (de) Hyterosalpingographie und selektive Salpingographie
DE69332484D1 (de) Rapamycinderivate
DK0700353T3 (da) Selvlukkende arrangement
PT900210E (pt) Derivados azahexano heterociclicos com actividade antviral
DE69619661D1 (de) 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-on-derivate mit pde iv-und cytokin-inhibisender aktivität
ITMI931518A0 (it) Derivati eparinici ad attivita' antimetastatica
NO910723D0 (no) Karbapenemderivater med antibiotisk aktivitet, samt fremstilling og anvendelse derav.
DE69332582D1 (de) Rapamycinderivate
MX9201681A (es) 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
NO905485D0 (no) Benzazepin- og benzotiazepin-derivater.
DE69637363D1 (de) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on-derivate mit pde iv und cytokin-inhibirendes aktivität
DE69635224D1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
DE69618694D1 (de) N-Acetylpiperazinderivat, antibakteriell und anti-ulcer Medikament
DE68906340D1 (de) Tetrahydronaphthalin und indan-derivate.
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
DK0731078T3 (da) Terpenquinon med antitumoraktivitet
DE69412083D1 (de) Phenylpyrrolderivate und ihre verwendung als antipsychotika
DE68919507D1 (de) 2-Pyridylmethylthio-Derivate und antiulzerierendes Mittel.
NO981939D0 (no) Tiomorfinaner med neurobeskyttende aktivitet
DE69223905D1 (de) Avermectin-Verbindungen mit einem 6,5-Spiroketal-Ringsystem und einem 23-Acyl-Substituenten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee